Disclosures for "Long-Term Risk of Cognitive Impairment with GLP-1 Analogues in Older Adults with Type 2 Diabetes Mellitus"
-
Mr. Thorman has nothing to disclose.
-
Author has nothing to disclose
-
Mr. Malhotra has nothing to disclose.
-
Mr. Sacknovitz has nothing to disclose.
-
Author has nothing to disclose
-
Michael C. Schubert, PT, MS has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANPT.
-
Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .